Do weight-loss drugs help psoriasis and HS?

Section 01

What has actually been found

The clearest result comes from a retrospective cohort study of people with diabetes. Those treated with GLP-1 receptor agonists developed hidradenitis suppurativa and psoriasis less often than comparable people who were not. That is a large group and a consistent direction.[1]

Alongside that sit reviews describing improvement in psoriasis severity scores and in quality-of-life scores, together with better blood sugar control and lower inflammatory markers. For hidradenitis there are case reports of people whose flares stopped, and a claims analysis reporting fewer HS-related operations.[2][3][4]

Taken together it is a real signal. It is not proof, and the distinction matters for what you do next.[1][2]

Section 02

Why it might work

There are two plausible explanations and they are hard to separate. The simple one is weight. Both conditions are worse in people carrying more weight, hidradenitis particularly so, where friction and skin folds matter directly. Losing weight improves both regardless of how you lose it.[3][2]

The more interesting explanation is that these medicines act on inflammation itself. Receptors for GLP-1 appear on immune cells, and treated people show falls in inflammatory markers that are larger than weight loss alone would predict. Reviews also describe effects on sebaceous gland activity, which is relevant to both acne and hidradenitis.[3][5]

Nobody has designed a study that separates the two. Until someone does, "the weight loss did it" remains the simplest explanation that fits everything.[2][3]

Section 03

What this does not mean

It does not mean a GLP-1 medicine is a treatment for psoriasis or hidradenitis. None is approved for either, none has been tested in a randomised trial for either, and the improvements reported are not on the scale that modern biologic treatments produce.[2][4]

It is not a reason to stop or delay a treatment that is working. If a biologic is controlling your psoriasis, that is a known quantity with trial evidence behind it. Swapping it for a weight-loss medicine on the strength of cohort data would be a poor trade.[4][2]

• No GLP-1 medicine is approved to treat psoriasis or hidradenitis suppurativa.[2]
• The published improvements come mostly from people who also had type 2 diabetes.[4]
• Weight loss by any route improves both conditions, which the studies cannot rule out as the whole explanation.[3]

Section 04

The conversation worth having

If you have psoriasis or hidradenitis and also have a reason to consider a weight-loss medicine, this research is a legitimate thing to raise. It tilts the balance slightly in favour, because the skin effect looks likely to be neutral or helpful rather than harmful.[1][4]

The useful question for a dermatologist is not "will this cure my skin" but "does this change anything about how we manage it". Weight, blood sugar and inflammation all interact with these conditions, and someone treating your skin should be interested in all three.[3][2]

Section 05

Holding both findings together

The same body of research documents facial volume loss, skin laxity and hair shedding. People taking these medicines report both: skin disease that troubles them less, and an appearance they are less happy with.[6]

That is not a contradiction and it is not a reason to distrust either finding. It is what a real trade-off looks like, and it is better to know about both halves before starting than to meet the second one by surprise.[6][2]